Push2Spin Technologies, Inc. develops a comprehensive “all-in-one” fat grafting system designed to simplify and improve the outcomes of fat grafting procedures in regenerative medicine. By integrating multiple steps of the grafting workflow into a single device, the company aims to reduce procedural complexity for clinicians while enhancing patient results. Push2Spin plans to leverage its technology to capture a meaningful share of the growing fat grafting and regenerative medicine markets. The company recently secured $1.2 million in seed capital, giving it resources to expand operations, scale manufacturing, and bolster R&D for next-generation product iterations. Management intends to deploy the fresh funding to meet anticipated demand and strengthen its competitive position. Although key usage or revenue metrics were not disclosed, the successful seed round signals investor confidence in the firm’s market potential and technical differentiation. Push2Spin ultimately aspires to solidify its leadership in fat grafting solutions through continued innovation and market expansion.

Total raised

$1M

Funding rounds

1

Latest round

Seed

Latest activity

Dec 2025